Volume 125, Issue 4 pp. 615-620
GASTRIC AND UGI

Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination

Hiroshi Kobayashi MD, MPH

Hiroshi Kobayashi MD, MPH

Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan

Department of Surgery, Southern TOHOKU General Hospital, Koriyama, Japan

Search for more papers by this author
Michitaka Honda MD, PhD

Corresponding Author

Michitaka Honda MD, PhD

Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan

Department of Surgery, Southern TOHOKU General Hospital, Koriyama, Japan

Correspondence Michitaka Honda MD, PhD, Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima-shi 960-1295, Japan.

Email: [email protected]

Search for more papers by this author
Hidetaka Kawamura MD, MPH

Hidetaka Kawamura MD, MPH

Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan

Department of Surgery, Southern TOHOKU General Hospital, Koriyama, Japan

Search for more papers by this author
Koichi Takiguchi MD

Koichi Takiguchi MD

Department of Surgery, The Takeda Healthcare Foundation Takeda General Hospital, Aizuwakamatsu, Japan

Search for more papers by this author
Atsushi Muto MD, PhD

Atsushi Muto MD, PhD

Department of Surgery, Fukushima Rosai Hospital, Iwaki, Japan

Search for more papers by this author
Shigeru Yamazaki MD, PhD

Shigeru Yamazaki MD, PhD

Department of Surgery, Ohta Nishinouchi Hospital, Koriyama, Japan

Search for more papers by this author
Yasushi Teranishi MD, PhD

Yasushi Teranishi MD, PhD

Department of Surgery, Southern TOHOKU General Hospital, Koriyama, Japan

Search for more papers by this author
Satoru Shiraso MD, PhD

Satoru Shiraso MD, PhD

Department of Surgery, Iwaki City Medical Center, Iwaki, Japan

Search for more papers by this author
Koji Kono MD, PhD

Koji Kono MD, PhD

Department of Gastrointestinal Tract Surgery, Fukushima Medical University, Fukushima, Japan

Search for more papers by this author
Soshi Hori MD

Soshi Hori MD

Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan

Department of Surgery, Southern TOHOKU General Hospital, Koriyama, Japan

Search for more papers by this author
Takahiro Kamiga MD, PhD

Takahiro Kamiga MD, PhD

Department of Surgery, Shirakawa Kosei General Hospital, Shirakawa, Japan

Search for more papers by this author
Toshiyasu Iwao MD

Toshiyasu Iwao MD

Department of Internal Medicine, Aidu Chuo Hospital, Aizuwakamatsu, Japan

Search for more papers by this author
Naoyuki Yamashita MD, PhD

Naoyuki Yamashita MD, PhD

Department of Surgery, Tsuboi Hospital, Koriyama, Japan

Search for more papers by this author
First published: 05 January 2022
Citations: 4

Hiroshi Kobayashi and Michitaka Honda contributed equally to this study.

Abstract

Background

The prognosis of gastric cancer patients with positive lavage cytology without gross peritoneal dissemination (P0CY1) is poor. The survival benefit of gastrectomy for these patients has not been established.

Patients and Methods

In this population-based cohort study, we investigated the impact of radical gastrectomy with lymph node dissection for P0CY1 patients. Patients who were diagnosed with Stage IV gastric cancer from 2008 to 2015 in all nine cancer-designated hospitals in a tertiary medical area were listed. Patients who were diagnosed with histologically proven adenocarcinoma in both the primary lesion and lavage cytology during the operation or a diagnostic laparoscopic examination were enrolled. Patients with a gross peritoneal lesion or other metastatic lesions were excluded. The primary outcome was the adjusted hazard ratio (aHR) of gastrectomy for overall survival. We also evaluated the survival time in patients who underwent gastrectomy or chemotherapy in comparison to patients managed without primary surgery or with best supportive care.

Results

One hundred patients were enrolled. The aHR (95% confidence interval) of gastrectomy was 0.677 (0.411–1.114, p = 0.125). The median survival time in patients who received gastrectomy (n = 74) was 21.7, while that in patients managed without primary surgery (n = 30) was 20.5 months (p = 0.155). The median survival time in patients who received chemotherapy (n = 76) was 23.0 months, while that in patients managed without chemotherapy was 8.6 months (p < 0.001).

Conclusion

Gastrectomy was not effective for improving the survival time in patients with P0CY1 gastric cancer. Surgeons should prioritize the performance of chemotherapy over surgery as the initial treatment.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

DATA AVAILABILITY STATEMENT

Research data are not shared due to privacy and ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.